These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36813655)

  • 1. Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome.
    Rioja J; Ariza MJ; Benítez-Toledo MJ; Espíldora-Hernández J; Coca-Prieto I; Arrobas-Velilla T; Camacho A; Olivecrona G; Sánchez-Chaparro MÁ; Valdivielso P
    J Clin Lipidol; 2023; 17(2):272-280. PubMed ID: 36813655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
    Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D
    J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activity.
    Brisson D; Larouche M; Chebli J; Khoury E; Gaudet D
    Clin Biochem; 2023 Apr; 114():67-72. PubMed ID: 36780934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
    Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S
    J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study.
    Rodriguez FH; Estrada JM; Quintero HMA; Nogueira JP; Porras-Hurtado GL
    Lipids Health Dis; 2023 Mar; 22(1):43. PubMed ID: 36978188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lipoprotein lipase-GPI-anchored high-density lipoprotein-binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome.
    Nimonkar AV; Weldon S; Godbout K; Panza D; Hanrahan S; Cubbon R; Xu F; Trauger JW; Gao J; Voznesensky A
    J Biol Chem; 2020 Mar; 295(10):2900-2912. PubMed ID: 31645434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes.
    D'Erasmo L; Di Costanzo A; Cassandra F; Minicocci I; Polito L; Montali A; Ceci F; Arca M
    Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2531-2541. PubMed ID: 31619059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.
    Ariza MJ; Rioja J; Ibarretxe D; Camacho A; Díaz-Díaz JL; Mangas A; Carbayo-Herencia JA; Ruiz-Ocaña P; Lamíquiz-Moneo I; Mosquera D; Sáenz P; Masana L; Muñiz-Grijalvo O; Pérez-Calahorra S; Valdivielso P;
    J Clin Lipidol; 2018; 12(6):1482-1492.e3. PubMed ID: 30150141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.
    Paquette M; Amyot J; Fantino M; Baass A; Bernard S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3473-e3482. PubMed ID: 34019660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in the LPL and GPIHBP1 genes, in patients with severe hypertriglyceridaemia, detected with high resolution melting analysis.
    Ariza MJ; Pérez-López C; Almagro F; Sánchez-Tévar AM; Muñiz-Grijalvo O; Álvarez-Sala Walter LA; Rioja J; Sánchez-Chaparro MÁ; Valdivielso P
    Clin Chim Acta; 2020 Jan; 500():163-171. PubMed ID: 31669931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
    Caddeo A; Mancina RM; Pirazzi C; Russo C; Sasidharan K; Sandstedt J; Maurotti S; Montalcini T; Pujia A; Leren TP; Romeo S; Pingitore P
    Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):158-164. PubMed ID: 29288010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical, Clinical, and Genetic Characteristics of Mexican Patients with Primary Hypertriglyceridemia, Including the First Case of Hyperchylomicronemia Syndrome Due to GPIHBP1 Deficiency.
    Rodríguez-Gutiérrez PG; Colima-Fausto AG; Zepeda-Olmos PM; Hernández-Flores TJ; González-García JR; Magaña-Torres MT
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene.
    Kim KY; Heo YJ; Ko JM; Lee YA; Shin CH; Ki CS; Lee YJ
    BMC Endocr Disord; 2024 Apr; 24(1):47. PubMed ID: 38622573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and functional characterization of familial chylomicronemia syndrome.
    Teramoto R; Tada H; Kawashiri MA; Nohara A; Nakahashi T; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Atherosclerosis; 2018 Feb; 269():272-278. PubMed ID: 29153744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency.
    Xia Y; Zheng W; Du T; Gong Z; Liang L; Wang R; Yang Y; Zhang K; Lu D; Chen X; Sun Y; Sun Y; Xiao B; Qiu W
    J Clin Lipidol; 2023; 17(6):808-817. PubMed ID: 37858495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.
    Beigneux AP; Franssen R; Bensadoun A; Gin P; Melford K; Peter J; Walzem RL; Weinstein MM; Davies BS; Kuivenhoven JA; Kastelein JJ; Fong LG; Dallinga-Thie GM; Young SG
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):956-62. PubMed ID: 19304573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations.
    Vigna GB; Citroni N; Tarugi P; Fellin R
    J Clin Lipidol; 2022; 16(5):591-595. PubMed ID: 35945124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
    Falko JM
    Endocr Pract; 2018 Aug; 24(8):756-763. PubMed ID: 30183397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pathogenic variant combination in
    Shi H; Wang Z
    Transl Pediatr; 2022 Oct; 11(10):1717-1725. PubMed ID: 36345447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".
    Moulin P; Dufour R; Averna M; Arca M; Cefalù AB; Noto D; D'Erasmo L; Di Costanzo A; Marçais C; Alvarez-Sala Walther LA; Banach M; Borén J; Cramb R; Gouni-Berthold I; Hughes E; Johnson C; Pintó X; Reiner Ž; van Lennep JR; Soran H; Stefanutti C; Stroes E; Bruckert E
    Atherosclerosis; 2018 Aug; 275():265-272. PubMed ID: 29980054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.